PPT-Genomic Engineering: Developing doxycycline-inducible CRISPR-Cas9 stable cell lines to

CAMKK2 in prostate cancer Alexander H Pham 123 Chenchu Lin 123 Daniel E Frigo 123 Shaun Zhang 12 1 Center for Nuclear Receptors and Cell Signaling 2 Department of Biology and Biochemistry University of Houston TX USA . DeMayo. FJ, Spencer TE. Jennifer Thornton. April 1, 2015. Happy April Fools’ Day!. *I won’t actually cover this paper, but it’s real and you should check it out at. http. ://www.ncbi.nlm.nih.gov/pubmed/25100711. Introduction to CRISPR. http://. www.addgene.org. /CRISPR/guide/. Wiedenheft. et al. Nature 2012. 3 distinct types of bacterial CRISPR systems identified so far:. Type I, II, III . Type II is the basis for current genome engineering applications. Breakthrough in genome editing.. The most important scientific result . of the year 2015.. “Science“,18 December 2015. I will report first about. Duchenne muscular dystrophy,. because there were serious problems . Nick Turner. Bio 446 Fall 16. Review. siRNA. dsRNA. microRNA. Immunity. Gene Regulation. Enzymatic breakdown of RNA. RNA Interference. RNAi. The use of RNA to inhibit gene expression.. Guiding RISC (RNA Induced Silencing Complex) cleave and degrade specific segments of RNA. The Wonderful World of CRISPR. As told by Professor Peter Shepherd. To do precise genetic engineering we need to be able to find and specifically modify regions of DNA. But the human genome has 3,000,000,000 base pairs so how are we going to find a 20 base pair region in this huge sea of DNA ? . FucU CRIPR/Cas9 KO Plasmid (m): sc-427279 Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 fax 831.457.3801 Europe + 00800 4573 8000 49 6221 4503 0 www.scbt.com BACKGR A Neiteler. 1,2,3,5. , S Borooah. 6. , BT Selvaraj. 2,3,5. , K Burr. 2,3,5. , B Dhillon. 2,4. , JA Ross. 1. , S Chandran. 2,3,5. 1. Tissue Injury and Repair Group, . 2. Centre for Clinical Brain Sciences, . González. Master in . Advanced. . Genetics. Universitat. . Autònoma. de Barcelona. GENOMICS. Introduction. Francisco J. M. Mojica . CRISPR. 2000. Source. : . Doudna. . y . Charpentier. , 2014. Introduction. for creation of. p53 knock-outs in . human . glioma . cells. :. a. research proposal by . gus. . thomas. Overview and Introduction:. Glioblastoma Multiforme (GBM):. Aggressive brain cancer. Very poor prognosis. successfully applied to directly produce low-copy integrated transgenic lines in C. eleganss10]. High copy integrated arrays are prone to be silenced, yet low-copy transgenes permit relatively stable The primary Sigma product number covered by this technical bulletin is:CRISPR for: Custom gRNA expression plasmids (including All-in-One and gRNA-only plasmids) T7-generated gRNA Lentiviral particl DEFINITIONS Genome Editing : This is a type of genetic engineering in which DNA is inserted, replaced, or removed from a genome using artificially engineered nucleases, or “molecular scissors”. ?. G. enetic . engineering. , the artificial manipulation, modification, and recombination of DNA or other nucleic acid molecules in order to modify an organism or population of organisms. . This . may mean changing one base . CHOPPED!. Using CRISPR/Cas9 to cut DNA. Today’s lab. In this lab, you will take a close-up look at the molecular machinery that makes CRISPR/Cas such a powerful genome editing tool!. Genome editing.